CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 1,302 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01468246
NCT01468246N/AActive

Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study

Dana-Farber Cancer Institute·observational·Posted Nov 9, 2011·Updated Feb 3, 2026

In Brief

An observational study for Breast Cancer. Active but no longer recruiting, targeting 1,302 participants across 13 sites in 2 countries.

Detailed Summary

The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women consent to the study, they fill-out surveys and give blood samples, and the investigators collect tissue from their breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an additional 7 years (for a total follow-up of at least 10 years following diagnosis). The study investigates short and long-term disease and treatment issues, tumor biology and the relationship to patient outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young women who are newly-diagnosed with breast cancer.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada, United States
Collaborators--

Timeline

N/AActive
20072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029203020312032203320342035
First PostedNov 9, 2011
Enrollment StartNov 1, 2006
Primary CompletionJan 1, 2035
TodayJul 2, 2026
Enrollment to primary: 28.2 yearsPosted 14.6 years agoPrimary completion in 8.5 years